{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:47:35Z","timestamp":1773798455831,"version":"3.50.1"},"reference-count":12,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Nephrol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0971-4065.98754","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T20:40:30Z","timestamp":1342816830000},"page":"189","source":"Crossref","is-referenced-by-count":5,"title":["Sevelamer carbonate experience in Indian end stage renal disease patients"],"prefix":"10.25259","volume":"22","author":[{"given":"G","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Kher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Jayakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Chafekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Pargaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. N. V","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. N. V","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0971-4065.98754-1","first-page":"248","volume-title":"Novel dosage forms and regimens for sevelamer-based phosphate binders","author":"Duggal","year":"2006","journal-title":"J Ren Nutr"},{"key":"key-10.4103\/0971-4065.98754-2","first-page":"694","volume-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.98754-3","first-page":"2907","volume-title":"Long-term effects of sevelamer hydrochloride on the calcium\u00d7phosphate product and lipid profile of haemodialysis patients","author":"Chertow","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.98754-4","doi-asserted-by":"crossref","unstructured":"Slatopolsky EA, Burke SK, Dillon MA. RenaGel. A nonabsorbed calcium- and aluminum-free phosphate binder, lowers serumphosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 1999;55:299-307.","DOI":"10.1046\/j.1523-1755.1999.00240.x"},{"key":"key-10.4103\/0971-4065.98754-5","first-page":"96","volume-title":"Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: A new phosphate binder for the treatment of hyperphosphatemia","author":"Joy","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key-10.4103\/0971-4065.98754-6","first-page":"386","volume-title":"A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis","author":"Delmez","year":"2007","journal-title":"Clin Nephrol"},{"key":"key-10.4103\/0971-4065.98754-7","first-page":"122","volume-title":"Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy","author":"Mathew","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key-10.4103\/0971-4065.98754-8","first-page":"1653","volume-title":"Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density","author":"Asmus","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/0971-4065.98754-9","first-page":"1815","volume-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.98754-10","first-page":"245","volume-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.98754-11","first-page":"438","volume-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"key-10.4103\/0971-4065.98754-12","first-page":"1261","volume-title":"Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis","author":"Gardham","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Indian Journal of Nephrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T19:42:48Z","timestamp":1712173368000},"score":1,"resource":{"primary":{"URL":"https:\/\/indianjnephrol.org\/sevelamer-carbonate-experience-in-indian-end-stage-renal-disease-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"alternative-id":["98754"],"URL":"https:\/\/doi.org\/10.4103\/0971-4065.98754","relation":{},"ISSN":["0971-4065"],"issn-type":[{"value":"0971-4065","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}